Status:
COMPLETED
Pilot Study to Estimate the Burden and Distribution of Plasmodium Falciparum Malaria in Kalifabougou, Mali in Preparation for a Prospective Cohort Study of Naturally-Acquired Malaria Immunity
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Conditions:
Malaria, Falciparum
Plasmodium Falciparum
Eligibility:
All Genders
Up to 25 years
Brief Summary
Plasmodium falciparum malaria remains a global public health threat. Leading malaria vaccine candidates confer only partial short-lived protection at best. An understanding of the mechanisms by which ...
Detailed Description
Plasmodium falciparum malaria remains a global public health threat. Leading malaria vaccine candidates confer only partial short-lived protection at best. An understanding of the mechanisms by which ...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- Cross-sectional Survey:
- Individuals (ages 2-25 years) are eligible to enter the cross-sectional study if they agree to:
- Live in Kalifabougou for the next 5 months.
- Have blood specimens stored for future studies.
- Passive Surveillance:
- All individuals who live in Kalifabougou and present to the Kalifabougou health center with suspected malaria will be eligible to enroll in the passive surveillance component of the protocol.
- EXCLUSION CRITERIA:
- None.
Exclusion
Key Trial Info
Start Date :
June 23 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 23 2013
Estimated Enrollment :
1719 Patients enrolled
Trial Details
Trial ID
NCT01160562
Start Date
June 23 2010
End Date
January 23 2013
Last Update
December 17 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Malaria Research and Training Center
Bamako, Mali